A meta-analysis of bias at baseline in RCTs of attention bias modification: No evidence for dot-probe bias towards threat in clinical anxiety and PTSD

Considerable effort and funding have been spent on developing Attention Bias Modification (ABM) as a treatment for anxiety disorders, theorized to exert therapeutic effects through reduction of a tendency to orient attention toward threat. However, meta-analytical evidence that clinical anxiety is c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruijt, A, Parsons, S, Fox, E
Formato: Journal article
Lenguaje:English
Publicado: American Psychological Association 2019
_version_ 1826283965104783360
author Kruijt, A
Parsons, S
Fox, E
author_facet Kruijt, A
Parsons, S
Fox, E
author_sort Kruijt, A
collection OXFORD
description Considerable effort and funding have been spent on developing Attention Bias Modification (ABM) as a treatment for anxiety disorders, theorized to exert therapeutic effects through reduction of a tendency to orient attention toward threat. However, meta-analytical evidence that clinical anxiety is characterized by threat-related attention bias is thin. The largest meta-analysis to date included dot-probe data for n = 337 clinically anxious individuals. Baseline measures of biased attention obtained in ABM RCTs form an additional body of data that has not previously been meta-analyzed. This article presents a meta-analysis of threat-related dot-probe bias measured at baseline for 1,005 clinically anxious individuals enrolled in 13 ABM RCTs. Random-effects meta-analysis indicated no evidence that the mean bias index (BI) differed from zero (k = 13, n = 1005, mean BI = 1.8 ms, SE = 1.26 ms, p = .144, 95% confidence interval [-0.6, 4.3]. Additional Bayes factor analyses also supported the point-zero hypothesis (BF10 = .23), whereas interval-based analysis indicated that mean bias in clinical anxiety is unlikely to extend beyond the 0 to 5 ms interval. Findings are discussed with respect to strengths (relatively large samples, possible bypassing of publication bias), limitations (lack of control comparison, repurposing data, specificity to dot-probe data), and theoretical and practical context. We suggest that it should no longer be assumed that clinically anxious individuals are characterized by selective attention toward threat. Clinically anxious individuals enrolled in RCTs for Attention Bias Modification are not characterized by threat-related attention bias at baseline. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
first_indexed 2024-03-07T01:06:44Z
format Journal article
id oxford-uuid:8b9b33d4-c6c1-4107-aef2-8b19cf4ac04f
institution University of Oxford
language English
last_indexed 2024-03-07T01:06:44Z
publishDate 2019
publisher American Psychological Association
record_format dspace
spelling oxford-uuid:8b9b33d4-c6c1-4107-aef2-8b19cf4ac04f2022-03-26T22:39:08ZA meta-analysis of bias at baseline in RCTs of attention bias modification: No evidence for dot-probe bias towards threat in clinical anxiety and PTSDJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8b9b33d4-c6c1-4107-aef2-8b19cf4ac04fEnglishSymplectic Elements at OxfordAmerican Psychological Association2019Kruijt, AParsons, SFox, EConsiderable effort and funding have been spent on developing Attention Bias Modification (ABM) as a treatment for anxiety disorders, theorized to exert therapeutic effects through reduction of a tendency to orient attention toward threat. However, meta-analytical evidence that clinical anxiety is characterized by threat-related attention bias is thin. The largest meta-analysis to date included dot-probe data for n = 337 clinically anxious individuals. Baseline measures of biased attention obtained in ABM RCTs form an additional body of data that has not previously been meta-analyzed. This article presents a meta-analysis of threat-related dot-probe bias measured at baseline for 1,005 clinically anxious individuals enrolled in 13 ABM RCTs. Random-effects meta-analysis indicated no evidence that the mean bias index (BI) differed from zero (k = 13, n = 1005, mean BI = 1.8 ms, SE = 1.26 ms, p = .144, 95% confidence interval [-0.6, 4.3]. Additional Bayes factor analyses also supported the point-zero hypothesis (BF10 = .23), whereas interval-based analysis indicated that mean bias in clinical anxiety is unlikely to extend beyond the 0 to 5 ms interval. Findings are discussed with respect to strengths (relatively large samples, possible bypassing of publication bias), limitations (lack of control comparison, repurposing data, specificity to dot-probe data), and theoretical and practical context. We suggest that it should no longer be assumed that clinically anxious individuals are characterized by selective attention toward threat. Clinically anxious individuals enrolled in RCTs for Attention Bias Modification are not characterized by threat-related attention bias at baseline. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
spellingShingle Kruijt, A
Parsons, S
Fox, E
A meta-analysis of bias at baseline in RCTs of attention bias modification: No evidence for dot-probe bias towards threat in clinical anxiety and PTSD
title A meta-analysis of bias at baseline in RCTs of attention bias modification: No evidence for dot-probe bias towards threat in clinical anxiety and PTSD
title_full A meta-analysis of bias at baseline in RCTs of attention bias modification: No evidence for dot-probe bias towards threat in clinical anxiety and PTSD
title_fullStr A meta-analysis of bias at baseline in RCTs of attention bias modification: No evidence for dot-probe bias towards threat in clinical anxiety and PTSD
title_full_unstemmed A meta-analysis of bias at baseline in RCTs of attention bias modification: No evidence for dot-probe bias towards threat in clinical anxiety and PTSD
title_short A meta-analysis of bias at baseline in RCTs of attention bias modification: No evidence for dot-probe bias towards threat in clinical anxiety and PTSD
title_sort meta analysis of bias at baseline in rcts of attention bias modification no evidence for dot probe bias towards threat in clinical anxiety and ptsd
work_keys_str_mv AT kruijta ametaanalysisofbiasatbaselineinrctsofattentionbiasmodificationnoevidencefordotprobebiastowardsthreatinclinicalanxietyandptsd
AT parsonss ametaanalysisofbiasatbaselineinrctsofattentionbiasmodificationnoevidencefordotprobebiastowardsthreatinclinicalanxietyandptsd
AT foxe ametaanalysisofbiasatbaselineinrctsofattentionbiasmodificationnoevidencefordotprobebiastowardsthreatinclinicalanxietyandptsd
AT kruijta metaanalysisofbiasatbaselineinrctsofattentionbiasmodificationnoevidencefordotprobebiastowardsthreatinclinicalanxietyandptsd
AT parsonss metaanalysisofbiasatbaselineinrctsofattentionbiasmodificationnoevidencefordotprobebiastowardsthreatinclinicalanxietyandptsd
AT foxe metaanalysisofbiasatbaselineinrctsofattentionbiasmodificationnoevidencefordotprobebiastowardsthreatinclinicalanxietyandptsd